June 2026 Research Brief
Active sponsors
Trials
Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors
Feasibilty and Acceptability of Amani
Expanded Access Protocol for Gene Therapy Utilizing shmiR Lentivirus Vector to Induce Fetal Hemoglobin in Sickle Cell Disease
Epidemiology of Invasive Bacterial Infections in Children With Sickle Cell Disease in France Between 2020 and 2025
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
Evaluation of an Information Management and Communication System for Population-wide Point-of-Care Infant Sickle Cell Disease Screening
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)
Ultrasound Acute Chest Syndrome Sickle Cell Disease
Tocilizumab for Acute Chest Syndrome
Showing trials with activity in the past 30 days. See the full Sickle Cell Disease research landscape →
Recently completed · awaiting results
Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease
Condition guide
Sickle Cell Disease — the full picture
Research landscape, trial types, and what eligibility typically looks like — written for patients but useful for everyone.
Monthly digest
Get this brief every month
We’ll email you the Sickle Cell Diseasebrief as soon as it’s published — no login required.
Coming soon